Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(337)
•••
Comment by jayjay2020on Mar 26, 2019 10:58pm
152 Views
Post# 29540343

RE:RE:RE:RE:RE:RE:Read Between The Lines (GENIUS AT WORK SEES POTENTIAL)

RE:RE:RE:RE:RE:RE:Read Between The Lines (GENIUS AT WORK SEES POTENTIAL)
Donbgamecock wrote:
jayjay2020 wrote:
Donbgamecock wrote:
jayjay2020 wrote:
YukonJer wrote:
Aph is not going to make a billion. The projected mj sales for 2019 are 1.2 Billion. Which at current sales. Is a stretch


He counting CC pharma and international business .  Not just Canada
 


Whats the 2020 projection for LATAM businesses?   


Columbia is a projected 30000 kg production site . Which should fall into 2020 revenue .


Right JJ20!   That doesnt include Jamaica or the pharm distribution company in SA.  



it is also predicted that Canada's MJ sales will be $6.5B. https://www.bnnbloomberg.ca/canada-s-legal-cannabis-market-by-the-numbers-1.1096027. It is a very conservative assumption that APHA could capture 10% of this revenue or $650M.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities